[Elsevier] ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice

Reubens3 Post time The day before yesterday 10:13 | Show all posts |Read mode

Reward10points

journal：Molecular Therapy

Authors：Kristen H. Schuster; Annie J. Zalon; Danielle M. DiFranco; Alexandra F. Putka; Nicholas R. Stec; Sabrina I. Jarrah; Arsal Naeem; Zaid Haque; Hanrui Zhang; Yuanfang Guan; Hayley S. McLoughlin

Published date：2024-5-

DOI：10.1016/j.ymthe.2024.02.033

PDF link：https://www.sciencedirect.com/sc ... 525001624001023/pdf

Article link：http://dx.doi.org/10.1016/j.ymthe.2024.02.033

Article Source：Elsevier BV。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

Reubens3 Lv.4

Senior Member

post
reply
points
4890

[Elsevier] ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice Copy

Reply

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice